Literature DB >> 17382163

Assessment of penile vibratory stimulation as a management strategy in men with secondary retarded orgasm.

Christian J Nelson1, Absaar Ahmed, Rolando Valenzuela, Marilyn Parker, John P Mulhall.   

Abstract

OBJECTIVES: To evaluate the effectiveness of penile vibratory stimulation for the management of retarded orgasm. Retarded orgasm, a condition characterized by difficulty achieving orgasm and ejaculation, is one of the most recalcitrant of the male sexual dysfunctions. Currently, no evidence-based treatments have been proven to ameliorate this condition.
METHODS: Men who had a complete inability to achieve an orgasm during sexual relations in the previous 3 months were instructed in the use of penile vibratory stimulation. The men's responses were measured by self-report of orgasm function and using the orgasm and satisfaction domains of the International Index of Erectile Function. The responses were assessed at baseline (admission into the study) and at 3 and 6 months.
RESULTS: A total of 36 men met the inclusion criteria, and 72% reported the restoration of orgasm. These responders reported that orgasm during sexual relations occurred 62% of the time. A statistically and clinically significant increase occurred in the orgasm and satisfaction domains of the International Index of Erectile Function between the baseline visit and the 3-month follow-up visit. These gains were sustained at 6 months.
CONCLUSIONS: Penile vibratory stimulation is an effective treatment for retarded orgasm. Penile vibratory stimulation should be integrated into current cognitive-behavioral sex therapy techniques to achieve maximal effectiveness and satisfaction.

Entities:  

Mesh:

Year:  2007        PMID: 17382163      PMCID: PMC4765806          DOI: 10.1016/j.urology.2006.02.048

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  17 in total

1.  Antidepressants and ejaculation: a double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone.

Authors:  M D Waldinger; A H Zwinderman; B Olivier
Journal:  J Clin Psychopharmacol       Date:  2001-06       Impact factor: 3.153

2.  Regarding ejaculation, delayed and otherwise.

Authors:  Michael A Parelman
Journal:  J Androl       Date:  2003 Jul-Aug

Review 3.  Empirically validated treatment for sexual dysfunction.

Authors:  J R Heiman; C M Meston
Journal:  Annu Rev Sex Res       Date:  1997

Review 4.  Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: the involvement of the serotonergic system.

Authors:  M D Waldinger; H H Berendsen; B F Blok; B Olivier; G Holstege
Journal:  Behav Brain Res       Date:  1998-05       Impact factor: 3.332

Review 5.  Retarded ejaculation reconceptualization and implications for treatment.

Authors:  G R Shull; D H Sprenkle
Journal:  J Sex Marital Ther       Date:  1980

6.  Reversal of fluoxetine-induced anorgasmia by cyproheptadine in two patients.

Authors:  S McCormick; J Olin; A W Brotman
Journal:  J Clin Psychiatry       Date:  1990-09       Impact factor: 4.384

7.  Yohimbine attenuates aging-induced sexual deficiencies in male rats.

Authors:  E R Smith; J M Davidson
Journal:  Physiol Behav       Date:  1990-04

8.  Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients.

Authors:  R J Kavoussi; R T Segraves; A R Hughes; J A Ascher; J A Johnston
Journal:  J Clin Psychiatry       Date:  1997-12       Impact factor: 4.384

9.  Sphincteric events during penile vibratory ejaculation and electroejaculation in men with spinal cord injuries.

Authors:  J Sønksen; D A Ohl; G Wedemeyer
Journal:  J Urol       Date:  2001-02       Impact factor: 7.450

Review 10.  Disorders of ejaculation.

Authors:  E A Jannini; C Simonelli; A Lenzi
Journal:  J Endocrinol Invest       Date:  2002-12       Impact factor: 4.256

View more
  6 in total

Review 1.  Delayed orgasm and anorgasmia.

Authors:  Lawrence C Jenkins; John P Mulhall
Journal:  Fertil Steril       Date:  2015-10-09       Impact factor: 7.329

2.  Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Crystal S Denlinger; Tara Sanft; K Scott Baker; Shrujal Baxi; Gregory Broderick; Wendy Demark-Wahnefried; Debra L Friedman; Mindy Goldman; Melissa Hudson; Nazanin Khakpour; Allison King; Divya Koura; Elizabeth Kvale; Robin M Lally; Terry S Langbaum; Michelle Melisko; Jose G Montoya; Kathi Mooney; Javid J Moslehi; Tracey O'Connor; Linda Overholser; Electra D Paskett; Jeffrey Peppercorn; M Alma Rodriguez; Kathryn J Ruddy; Paula Silverman; Sophia Smith; Karen L Syrjala; Amye Tevaarwerk; Susan G Urba; Mark T Wakabayashi; Phyllis Zee; Deborah A Freedman-Cass; Nicole R McMillian
Journal:  J Natl Compr Canc Netw       Date:  2017-09       Impact factor: 11.908

Review 3.  Clinical use and implications of sexual devices and sexually explicit media.

Authors:  Marieke Dewitte; Yacov Reisman
Journal:  Nat Rev Urol       Date:  2021-05-04       Impact factor: 14.432

Review 4.  Retarded ejaculation.

Authors:  Michael A Perelman; David L Rowland
Journal:  World J Urol       Date:  2006-12       Impact factor: 3.661

Review 5.  Delayed Ejaculation: Pathophysiology, Diagnosis, and Treatment.

Authors:  Ibrahim A Abdel-Hamid; Omar I Ali
Journal:  World J Mens Health       Date:  2018-01       Impact factor: 5.400

Review 6.  Psychosexual therapy for delayed ejaculation based on the Sexual Tipping Point model.

Authors:  Michael A Perelman
Journal:  Transl Androl Urol       Date:  2016-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.